trending Market Intelligence /marketintelligence/en/news-insights/trending/5WbX76Pruu78R4INtKe69w2 content esgSubNav
In This List

Catalyst Biosciences closes common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Catalyst Biosciences closes common stock offering

Catalyst Biosciences Inc. closed its underwritten public offering of 1,105,263 common shares at $9.50 apiece with gross proceeds of about $10.5 million.

JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. acted as joint book-running managers. LifeSci Capital LLC served as a co-manager for the offering.